Description

Satayathum et al identified risk factors for primary infection or reinfection with Schistosoma haematobium in pediatric patients in Kenya. This can help identify patients who may benefit from screening and therapy. The authors are from Case Western Reserve University, Maseno University (Kenya) and the Ministry of Health in Nairobi, Kenya.


 

Patient selection: males and females 5 to 20 years old, enrolled in a school-based Schistosomiasis treatment program

 

Parameters:

(1) age of the patient

(2) risk of schistomiasis for the village or community

(3) hematuria

(4) completeness of treatment

 

Risk factors for infection or reinfection:

(1) age < 12 years of age

(2) residence in high risk > intermediate risk > low risk community

(3) any level of hematuria by dipstick at entry into program

(4) failure to complete treatment regimens (or not being enrolled in school)

 

Factors to monitor for impact on the patient:

(1) chronic anemia

(2) growth retardation

(3) impaired cognitive and physical development

 

These factors can help identify patients who may benefit from interventions to reduce risk of acquiring the infection and to treat the disease.

 


To read more or access our algorithms and calculators, please log in or register.